Add-on benefits in antihypertensive patients
Additional Indication for Telmisartan
Based on ONTARGET Trial: Telmisartan is the only ARB approved for CV PREVENTION1,2
- The ONTARGET Investigators; Yusuf S, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547-59.
- MICARDIS® 80mg Malaysia Prescribing Information.
Renal function is closely associated with CV Risk1
- Ruilore LM. Acta Diabetol. 2005:42 Suppl 1:S33-41.
- Delles C, et al. Am J Hypertens. 2008;21(12):1330-1336.
- Schmieder RE. J Hypertens, Suppl. 2006;24(2):S31-35.
- Barnett AH, et al. N Engl J Med. 2004;351(19):1952-1961.
- Makino H, et al. Hypertens Res. 2008;31(4):654-664.
- Bichu P, et al. Vasc Health Risk Manag. 2009;5(1):129.40.
- Galle J, et al. Nephrol Dial Transplant. 2008;23(10):3174-83.
